İnvestigating Dysphagia in Pediatric Dystonia
NCT06815757 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2025-02-11
Summary
Dystonia is a movement disorder involving involuntary, sustained, or intermittent muscle contractions that cause abnormal postures and repetitive movements, worsened by voluntary actions or stress. It is linked to dysfunctions in the basal ganglia, thalamus, and cerebellum, affecting sensorimotor integration. In children, dystonia often coexists with other disorders like spasticity in cerebral palsy, complicating diagnosis and treatment.
Dystonia can be genetic, caused by mutations, or acquired, associated with conditions such as cerebral palsy, perinatal brain injury, and metabolic disorders. A key complication of pediatric dystonia is swallowing dysfunction (oropharyngeal dysphagia), which impairs airway protection and nutrition, increasing the risk of aspiration pneumonia. Studies have shown swallowing impairments across all phases (oral, pharyngeal, and esophageal) in children with dyskinetic cerebral palsy.
However, due to pathophysiological differences between dystonia and cerebral palsy, generalizing findings may lead to inaccuracies. Each dystonia subtype presents unique challenges that affect swallowing function, emphasizing the need for condition-specific assessment and interventions. This study aims to fill the research gap by exploring the clinical features of swallowing dysfunction in children with dystonia, providing insights to improve care and outcomes.
Conditions
- Dystonia Disorder
Sponsors & Collaborators
-
Gazi University
lead OTHER
Principal Investigators
-
Muserref Keles, PhD · Gazi University
Eligibility
- Min Age
- 2 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-17
- Primary Completion
- 2025-02-20
- Completion
- 2025-04-17
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment
NCT00004758 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
NCT00607542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Molecular Genetics in Infantile Spasms
NCT02885389 ·Status: COMPLETED
-
Prednisolone in Infantile Spasms- High Dose Versus Usual Dose
NCT01575639 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea
NCT00615797 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Lidocaine Block in Children With Cerebral Palsy and Dysphagia
NCT06304090 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Prevent Infantile Spasms Relapse
NCT06819670 ·Status: RECRUITING ·Phase: PHASE2
-
Recurrent Crying Spells in Cerebral Palsy
NCT01955655 ·Status: COMPLETED ·Phase: PHASE4
-
Ketogenic Diet vs ACTH for the Treatment of Children With West Syndrome
NCT05279118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of Neuroinflammation in Children With Infantile Spasms
NCT02092883 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Muscle Strength and Motor Ability in Children With Spinal Muscle Atrophy(SMA) Treated With Valproic Acid
NCT01033331 ·Status: COMPLETED
-
The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients
NCT02470325 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)
NCT02829827 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study
NCT00871455 ·Status: COMPLETED ·Phase: NA
-
Effects of L-Carnitine on Gastric Emptying in Children With Drug Resistant Epilepsy on Ketogenic Diet
NCT06255873 ·Status: COMPLETED ·Phase: NA
-
Trial of the Modified Atkins Diet in Infantile Spasms Refractory to Hormonal Therapy
NCT01549288 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms
NCT02299115 ·Status: WITHDRAWN ·Phase: PHASE3
-
Cortical Excitability in West Syndrome Using Transcranial Magnetic Stimulation
NCT06201897 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1
NCT01586052 ·Status: COMPLETED ·Phase: PHASE1
-
Doxycycline for the Treatment of Nodding Syndrome
NCT02850913 ·Status: UNKNOWN ·Phase: PHASE2
-
A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms
NCT00441896 ·Status: COMPLETED ·Phase: PHASE2
-
What Are the Determinant Factors of Ceasing Anti-seizure Medication in Infants With Neonatal Seizures?
NCT06211192 ·Status: COMPLETED
-
Catatonia in Nodding Syndrome and Lorazepam Treatment
NCT02462109 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Dexmedetomidine on Decreasing Emergence Agitation and Delirium in Pediatric Patients Undergoing Strabismus Surgery
NCT01512355 ·Status: COMPLETED ·Phase: NA
-
Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy
NCT01405950 ·Status: TERMINATED ·Phase: PHASE1